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Abstract  
Nearly half of pregnant women in the world are reported to suffer anemia. And most of 
them are caused by iron deficiency, while the others by folate, vitamin B12 or vitamin A 
deficiency, chronic inflammation, parasite infections and hereditary disorders. Anemia in 
pregnant women is characterized when <11 g/dL or any time during pregnancy. And when 
followed by low iron, it's called iron deficiency anemia. 
Iron plays an important role in many metabolic processes by transporting oxygen and 
allowing cells to generate energy. Low iron levels during pregnancy leading to anemia, 
related to an heightened risk of mother and fetus disease. Iron deficiency anemia can 
affect fetal development and persist long-term, while mild and serious pregnancy anemia 
can lead to premature birth, maternal and child mortality, bleeding, and infectious disease. 
The iron requirement during pregnancy exceeds 1000 mg for red cell expansion, 300 mg – 
350 mg for developing fetus and placenta, and 250 mg for variable blood loss at delivery. 
Iron adequacy during pregnancy can be assured by proper nutrition, iron supplementation 
and fortification, and intravenous iron or blood transfusion. Iron supplementation is only 
enough to cover the prenatal iron requirements. 
Summary: Iron deficiency leading to anemia, rising risk of negative pregnancy outcomes. 
To meet increasing iron requirements during pregnancy including iron supplementation, 
fortification of staple iron foods, and intravenous iron or blood transfusion if required.  




Macro-elements and micro-elements are important 
for the proper functioning of living organisms. Iron, 
which is mostly inorganic, is an essential 
micronutrient and plays a major part in many of the 
human body's metabolic processes, including 
oxygen transport, oxidative metabolism, and cell 
growth.1-3  
Approximately 3-5 g iron is present in the adult 
human body (44-55 mg per kg body weight in adult 
men & women), with hemoglobin incorporating 
more than 2/3, a four-unit molecule, one heme group 
and one protein chain that can be fully oxidized into 
the lungs and can be carried out by the lungs via the 
arteries to all cells across the body.2,4,5 The 
erythrocytes contain many of the iron in the body, 
such as hemoglobin, whilst ferritine and 
hemosiderin contain many enzymes in the liver, 
spleen, bone marrow and myoglobin, including 
catalase, peroxidase and cytochrome.3,5  
The intake of iron is present in both iron to heme 
(10%) and those without heme (90%). Heme iron 
includes any type of iron from animal products in 
which the iron is chemically bonded within the 
porphyrin ring structure as shown in both myoglobin 
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and hemoglobin. Iron that is not heme iron is called 
non-heme iron.3,5,6  
Iron absorption occurs in the small intestine 
specifically in the duodenum and the upper portion 
of the jejunum.1,6,7 Heme irons are soluble and are 
easily absorbed by a less unknown process of heme 
oxygenase 1 (HO-1) through the brush boundary of 
the enterocyte. Non-heme iron occurs in the 
intestinal lumen as an oxidized form of Fe3+ (ferric) 
and transformed to Fe2+ (ferrous) form either via a 
brush boundary membrane ferric reductase, 
probably a duodenal cytochrome b (Dcytb), or by a 
dietary reducing agent before it can be transported 
via the intestinal epithelium by a transporter called 
the divalent metal transporter 1 (DMT1) together 
with zinc, copper.1  
It is important to ensure the balance of iron 
homeostasis in the body as iron plays an integral role 
in several metabolic processes. Iron homeostasis is 
also required to prevent iron toxicity, non-protein 
bound iron (NPBI) reacts with oxygen and produces 
reactive oxygen species ( ROS) with the ability to 
damage DNA, proteins, lipids, other cellular 
molecules and stem cells.1,7,8 Iron homeostasis is 
controlled by a hepatocyte-producing hormone 
receptor and binds to ferroprotein named hepcidin 
(hepatic bactericidal protein) by control of intestinal 
and tissue release of iron. When iron storage and 
availability are limited, the amount of hepcidin is 
limited so that any excess absorbed in the gut or 
deposited in tissues is released. The contrary is true 
when storage and bioavailability are high. Then, the 
amount of hepcidin increases and controls the 
release of iron from the body through the plasma.4,7-
11  
 
The role of iron in maternal and fetal health 
 
Iron has been discovered to be necessary for vital 
physiological body functions, e.g. oxygen transport, 
hemoglobin and myoglobin synthesis, and cell 
growth and differentiation.[1]  
The average adult body contains around 3–5 g of 
iron (45–55 mg/kg adult men's body weight).2 Iron 
requirements increase dramatically during 
pregnancy to support an increasing volume of red 
cells, growing fetuses and placenta plus any 
expected or unforeseen blood loss at delivery, 
particularly with caesarean delivery.5,12 The need for 
iron for pregnancy is more than 1000 mg, 500 for 
red cell enlargement, 300-350 for fetal and placental 
development, and 250 for variable blood loss when 
delivered.7,13  
Iron is vital for the production of hemoglobin and 
is required during pregnancy for the development of 
the fetal brain. Throughout pregnancy., it is 
necessary to maintain an adequate maternal diet only 
enough to provide the critical nutrient for fetal 
development and birth outcomes. The disparity in 
maternal nutrition contributes to a rise in the risk of 
chronic post-life disease.14 
 
Maternal health related to iron 
 
The iron requirement increases during pregnancy, 
the maternal hematological system undergoes 
physiological changes to accommodate the growth 
of the fetus and placenta throughout pregnancy. 
Plasma volume increases and the red cell mas 
duplicates to ensure proper circulation and oxygen 
supply to the maternal organs including to the 
placenta for fetal development and to promote the 
impact of blood loss during supply.12,14-16  
Iron deficiency is a major micronutrient 
deficiency in the world. The prevalence of iron 
deficiency between expectant mothers, babies and 
young children may be due to high iron requirements 
during periods of rapid development.8,14,17 
Pregnancy anemia is the result of nutritional 
deficiency due to the lack of iron and folate in the 
diet, but other factors can additionally cause anemia 
including decreased absorption, chronic blood loss, 
increased demand, concomitant medical disorder, 
and malaria.18 That describes gestational anemia as 
a hematocrit <33 % and/or hemoglobin < 11 g/dL or 
at any time during pregnancy. The Centers for 
Disease Control and Prevention (CDC) describes 
anemia as hemoglobin < 11 g/dL and/or hematocrit 
less than 32 % in the first and third quarters and 
hemoglobin < 10.5 g/dL and/or hematocrit less than 
32 % in the second.7,13,19  
Women who are pregnant are identified to have 
adverse maternal and newborn health effects and 
make a greater threat of death during pregnancy and 
during the post-natal period. The potential negative 
health consequences for the mother include fatigue, 
weakened immune function, reduced tolerance to 
blood loss during delivery, an increased risk of 
infection, and a shortened lifespan due to heart 
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failure. Postpartum depression and behavioral 
problems exist in some cases of childbirth. Anemia 
during pregnancy is linked to several health risks 
including preterm birth or low birth weight. Preterm 
and Low Birth Weight are still the leading causes of 
neonatal death in some of the countries, often 
associated with an increased risk of intrauterine 
death, a low APGAR score of 5 minutes, and an 
intrauterine growth restriction.10,19-23 The A study 
confirms a connection between low hemoglobin 
levels in women during pregnancy and possible 
increased risk for postpartum hemorrhage and 
includes evidence of a connection between extreme 
anemia and uterine atony requiring emergency 
hysterectomy.18  
 
Fetal health related to iron 
 
Restricting fetal growth is significant for 
determining a child's health in the immediate future. 
Infants who do not grow to their maximum size are 
at higher risk of dying in their first year and of 
developing chronic diseases later in life, including 
coronary heart disease and type 2 diabetes. The 
infant is dependent on certain nutrients passed from 
mother to child. However, maternal nutrition plays a 
vital role in fetal development, and it is during the 
first trimester when fetal growth is most vulnerable. 
Iron deficiency is by far the greatest micronutrient 
deficiency. Data indicates that early pregnancy iron 
deficiency has an adverse effect on fetal 
development. Maternal anemia frequently exhibits a 
risk of low birth weight, either due to premature 
birth or reduced fetal growth linked to IDA, or due 
to delayed neurocognitive development.10,14,24 Iron 
is essential for enzymes involved in specific cerebral 
functions including serotonin and dopamine, a 
precursor to epinephrine and norepinephrine, 
myelination and production of neurotransmitters.14  
There is evidence that iron deficiency during 
pregnancy and/or anemia later in pregnancy affects 
learning, motor and emotional development, and 
children who experience perinatal iron deficiency 
are at greater risk of failing to meet educational 
goals. In addition, children who also undergo iron 
deficiency are more likely to bear as adults. As a 
result, a shortage of iron in one generation will lead 
to a shortage of iron in the next. Given the possible 
neurological effects, such as stunted motor 
development, lower IQ, learning disabilities, and 
memory deficits.25,26 
An alteration in the gut microbiome through an 
increase in intestinal iron results in the growth of 
potentially pathogenic bacteria. By at least one week 
of life, elevated intraluminal iron is most likely to 
occur in elevated dietary iron intake, inflammation, 
or both. Both are states characterized by low iron 
absorption as well as high levels of non-absorbed 
iron that remain intraluminal. Whether changing the 
microbiome increases the incidence of infectious 
diseases is a significant issue. These findings will 
likely affect future policy decisions.8 The main 
nutritional function of iron is to promote post-birth 
erythropoiesis, with insufficient preterm infant iron 
stores unable to support post-natal erythropoiesis 
and post-birth development.13  
 
 
Risk factors for iron deficiency in maternal, infancy, 
and toddlerhood 
 
Iron is typically in low amounts in diets. If iron is 
not being absorbed from the diet the person may 
have a nutritional iron deficiency.1 Iron deficiency 
anemia is the highly typical form of anemia that 
occurs in adolescents and has several risk factors 
ranging from low iron intake, menstrual status and 
pattern, obesity, socio-economic and malnutrition as 
risk factors for IDA, especially in developing 
countries.27 Maternal pregnancy smoking and 
pregestational or gestational diabetes mellitus are 
major risk factors for low fetal iron status.14 Iron 
deficiency in pregnancy is one of the most 
commonly diagnosed causes of pregnant women's 
health issues and the poor health of newborns. The 
factors of primary food shortages, parasites, and 
parasitic disease during pregnancy are major causes 
of anemia.28  
Iron accretion occurs during the third quarter of 
pregnancy. Infants have enough iron at birth to cover 
their iron needs during the first four to six months. 
Iron transfer from mothers to children in conditions 
like diabetes is reduced, but in children less than 5 
years of age, iron is not impaired by maternal anemia 
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Management of iron deficiency during pregnancy 
and lactation  
 
Iron and anemia are important health indicators in 
mothers and in children. Iron deficiency is a 
significant health issue for pregnant women before, 
during, and after pregnancy and this deficiency 
directly associates with negative pregnancy 
outcomes. Effective management is crucial to 
minimize the need for red cell transfusion, and 
especially the need for transfusions for a pregnant 
woman. The purpose of encouraging iron 
fortification during pregnancy is to reduce maternal 
morbidity, to provide sustenance for the fetus, and 
to prepare a newborn for early postnatal life. The 
growing evidence supports the notion that prenatal 
iron status affects iron status in the children.8 
During pregnancy, a mother takes in an average 
of 1,000 mg of iron. The baby's dosage rose from 6 
mg/day in the first trimester to 19 mg/day in the 
second trimester to 22 mg/day in the third. Unlike 
the recommendation for non-pregnant, non-lactating 
women, the recommendation for lactating women is 
based on only the presumption of lactation-induced 
amenorrhea and does not take into account that some 
women enter or end iron insufficiency or deficiency 
during pregnancy.7,13,30  
UK guidelines recommend that pregnant women 
be advised of iron-rich food sources and any factors 
that may inhibit or promote iron absorption, as well 
as why fulfilling iron requirements during 
pregnancy is beneficial. The recommended daily 
intake of iron as a function of age is approximately 
27 mg in the UK and 30-60 mg in most other 
countries.7,16,31,32 The estimated population 
requirement or average population requirement 
(AR) ranges from 7 mg/day to 22 mg/day and the 
recommended daily dietary allowance (RDA) or 
population nutrient intake (PNI) or recommended 
dietary intake (RNI) ranges from 11.5 mg/day to 27 
mg/day for 97.5 mg/day in the population.9  
During pregnancy, iron absorption triples, 
with the woman's iron requirement rising from 1-2 
mg to 6 mg per day. The foods with the highest 
levels of dietary heme iron are red meat, poultry, and 
fish. Heme or non-heme iron absorb 2-3 times faster. 
The food as a whole has many other organic 
compounds. that enhance the bioavailability of non-
heme iron in other sources. Vitamin C (ascorbic 
acid) aids in the absorption of iron by non-heme 
foods, thus increasing vitamin C in the meal. 
Fermentation and germination increase the 
bioavailability of non-heme iron by reducing the 
phytate content, an inhibitor for iron absorption. 
Coffee and tea tannins hinder the absorption of iron 
in the body. If a woman becomes iron-deficient in 
pregnancy, she must be supplemented through diet 
or by taking oral formulas. The minimum daily 
dosage of iron for iron deficiency is 100-200 mg. 
High doses of these nutrients should be avoided, as 
high doses cause increased oxidative stress and an 
increased risk of infection.33,34 For better purposes, 
it is advised to take iron supplements on an empty 
stomach because it is absorbed less efficiently when 
taken on a full stomach.30,31 The increase in 
hemoglobin levels in the blood indicates a positive 
response to the treatment and supports the diagnosis. 
The maximum rate of iron absorption is 20 to 25 % 
among individuals who are iron deficient when 
taking oral iron supplements. The effectiveness of 
oral iron supplementation is reduced when intestinal 
absorption is compromised (e.g., in celiac disease, 
autoimmune gastritis, ACD, or post-gastric or 
duodenal resection,) or the iron loss is significant 
and/or persistent. Adherence to oral iron therapy can 
be an obstacle to treatment since a patient may 
experience GI adverse reactions such as nausea, 
epigastric pain, diarrhea and constipation.35,36 
Intake of intravenous iron helps treat the 
symptoms of iron-deficiency anemia. Parenteral 
therapy can be used in patients unable to consume or 
tolerate oral therapy, such as those who have 
undergone gastrointestinal surgery or pregnant 
women who have experienced inadequate oral 
therapy. In patients with confirmed iron deficiency 
anaemia and Hb <100 g/L after 34-week gestation, 
IV iron should be considered. Blood transfusion is 
recommended for pregnant women with hemoglobin 
levels less than 8 g/dL unless reassuring fetal cardiac 
tracing and normal amniotic fluid volume is 
present.35,37 Two units of packed red blood cells 
should be administered if transfusion is performed, 
and the condition of the patient should be re-
evaluated to guide future care.35 Transfusion is 
simply a short-term solution for a problem, and 
proper care must include the diagnosis and treatment 
of the underlying condition. In addition, intravenous 
iron (as well as erythropoiesis-stimulating agents, if 
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necessary) tends to maintain Hb levels and iron 




Iron deficiency during pregnancy provides women 
and their babies with better outcomes. The 
usefulness of iron supplementation more than 
counterbalances any dangers to pregnant women 
that lack iron. During pregnancy, the mother's body 
requires an increased amount of iron to support the 
growth of red blood cells, fetus, and placenta and 
blood loss at delivery. During pregnancy, meeting 
the iron requirement is vital to preventing adverse 
health outcomes for the mother, child, and fetus. The 
most prevalent nutrient deficiency worldwide is iron 
deficiency, and it is most prevalent in pregnant 
women because the additional iron critical for fetal 
development is not readily received by the mother's 
body. WHO recommends universal oral iron 
supplements for pregnant women. The 
recommendation to take iron or iron-folic acid 
supplements to reduce the risk of adverse pregnancy 
outcomes and increase offspring iron stores. 
Provision of low doses of iron and folic acid when 
stores are nearly depleted is the most effective and 
safest way to achieve iron status. 
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